Tech spend is expected to increase to $2.9 trillion by 2021. We are looking at a seismic shift in the scaling of digitization at a pace never seen before, said Rakesh Rathi

Spokespeople for Pfizer, Moderna and AstraZeneca have said that pork products are not part of their COVID-19 vaccines. But limited supply and preexisting deals worth millions of dollars with other companies means that some countries with large Muslim populations, such as Indonesia, will receive vaccines that have not yet been certified to be gelatin-free

The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research

The company said that it has been listed ahead of global pharma companies such as Roche, Eli Lilly, Abbott, Novartis, and Pfizer in this year's rankings

Analysts polled by Refinitiv had, on average, forecast $3.2 billion

Eminent Indian-origin academician Srikant Datar will become the 11th dean in the business school history

The two countries argue that in the absence of a waiver, existing protection for intellectual property rights such as patents, industrial designs, copyright and protection of undisclosed information, may create barriers to timely access to affordable medical products

They state that access to means to fight COVID-19 on a global scale requires financial resources, assets, infrastructure, and jurisdictional support and collaboration beyond the capacity or role of each one of them

The U.S. Department of Justice said on Wednesday the settlement resolves allegations that Gilead improperly used the Caring Voice Coalition as a conduit to cover thousands of patients' co-payment obligations

Share market live: Top Sensex losers are IndusInd Bank, PowerGrid and Asian Paints falling over 1%

In the first quarter, Novartis including its generics division Sandoz, benefited from hospitals stocking up on medicines, for fear that the new coronavirus' spread would leave them short of supplies

BioNTech said testing of two dosages of its BNT162b1 drug on 24 healthy volunteers showed that after 28 days they had developed higher levels of COVID-19 antibodies than typically seen in infected people

Acting U.S. Attorney Audrey Strauss in Manhattan called the incentives for doctors \"nothing more than bribes,\" and said federal healthcare programs paid hundreds of millions of dollars in reimbursements for prescriptions tainted by kickbacks

Stocks to watch today on June 22: Glenmark Pharma, HDFC, HDFC Bank, Cipla, Bajaj Electricals, Cadila and Dhanlaxmi Bank among others are the top stocks to watch out for in Monday's trading session.

Novartis' board approved appointment of Sanker Parameswaran as an additional director (Independent and Non-Executive) of the company, to hold office for a period of 5 consecutive years with effect from June 22, 2020

Glenmark's current portfolio consists of 164 products authorised for distribution in the US marketplace and 44 abbreviated new drug applications pending approval with the USFDA

Stock Market LIVE Updates on June 19: Bajaj Finserv, Bajaj Finance, ONGC, Tata Steel, JSW Steel were maong the top gainers today. Infosys, HCL Tech, Wipro, Adani Ports, M&M were among the top losers

Stocks to watch today on June 19: RIL, Cipla, Bajaj Consumer, Whirlpool, City Union Bank, PNB, LIC Housing, Oil India, Cadila among others are the top stocks to watch out for in Friday's trading session

Whether India develops a Covid-19 vaccine/drug or not, Indian companies will be preferred partners for global pharma to make and distribute the life-saving drug globally

Though the government's SAUBHAGYA scheme claims to have provided connections to 100 per cent households, that is not sufficient. Under this scheme, the beneficiary households were provided only one LED light and one power plug, says Shailendra Roy